Dr Banerjee aims to set up three studies to improve our understanding of how damaging proteins in the brain may increase the risk of stroke. This can lead the way for researchers to find out how we can help more people avoid damage to their brain caused by these proteins.
Around 15% of strokes are haemorrhagic (due to bleeding in or around the brain). This guide explains the two different types of stroke caused by a bleed, intracerebral and subarachnoid haemorrhage, and how they are diagnosed and treated.
Cerebral venous thrombosis (CVT) is an unusual form of stroke. The study will provide a much better understanding of the reasons underlying CVT, which is an unusual but very important cause of stroke in young (mainly female) adults.
People with stroke due to brain hemorrhage have swelling around the hemorrhage on their brain scan. This programme is about understanding the effect of blood on brain cells, with a focus on finding treatments.
This project aims to demonstrate that failure of drainage of fluid from the grey and white matter of the brain is a mechanism underlying Small Vessel Disease, a condition that affects the small blood vessels in the brain which can cause stroke and dementia.
This study involves using genetics to understand why disease of the small blood vessels occurs in the brain.
Small Vessel Disease (SVD) is a disease of the small blood vessels in the brain and can lead to stroke and dementia. At the moment, we don't know how to stop SVD developing, or how to treat it. This Lectureship aims to improve future clinical trials that aim to prevent SVD.
In this study, we are testing the theory that by treating BP more intensively we will delay progression of the disease. We will also use state-of-the-art MRI imaging techniques to look at the mechanisms by which any beneficial effect of BP occurs.
This study is investigating how to make thoracic endovascular aortic stenting (TEVAR), treatment for thoracic aortic disease (TAD), safer by using extra protection devices.
This research is focused on assessing the relationship between the variability of the blood flow through the blood vessels supplying the brain, and the risk of stroke in patients who have already had a stroke or “mini-stroke” (TIA) in the past.